Wuhan YZY Biopharma Co., Ltd. (02496.HK) was successfully listed on the Main Board of Hong Kong Stock Exchange on September 25, 2023.

As the domestic legal adviser to the issuer, Jingtian & Gongcheng’s legal team assisted the company handling all matters related to Chinese laws throughout the listing.